Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoxianggou is a traditional herbal medicine originating from the She ethnic minority in China, typically identified as the plant *Uncaria hirsuta* Havil. It is primarily utilized in traditional She medicine for its anti-inflammatory and analgesic properties. In clinical settings, it is frequently administered via fumigation therapy—a process where the patient is exposed to the steam of the boiling herb—to treat musculoskeletal disorders such as knee osteoarthritis. The treatment is believed to improve local blood circulation, reduce swelling, and alleviate joint pain and stiffness by modulating inflammatory pathways, a characteristic effect of the alkaloids found in *Uncaria* species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoxianggou.